James A. Smith

Latest from James A. Smith

Emerging Platform Bioprocesses for Viral Vectors and Gene Therapies
Emerging Therapeutics
Emerging Platform Bioprocesses for Viral Vectors and Gene TherapiesEmerging Platform Bioprocesses for Viral Vectors and Gene Therapies
byDavid A. Brindley, Maya Fuerstenau-Sharpand 8 more
Apr 18, 2016
Automation of CAR-T Cell Adoptive Immunotherapy Bioprocessing: Technology Opportunities to Debottleneck Manufacturing
Personalized Medicine
Automation of CAR-T Cell Adoptive Immunotherapy Bioprocessing: Technology Opportunities to Debottleneck ManufacturingAutomation of CAR-T Cell Adoptive Immunotherapy Bioprocessing: Technology Opportunities to Debottleneck Manufacturing
byDavid A. Brindley, James A. Smithand 11 more
Apr 18, 2016

All from James A. Smith

Therapeutic Gene Editing: Tools to Facilitate Basic Science or Stimuli for a Paradigm Shift in Biomanufacturing?
Personalized Medicine
Therapeutic Gene Editing: Tools to Facilitate Basic Science or Stimuli for a Paradigm Shift in Biomanufacturing?
Therapeutic Gene Editing: Tools to Facilitate Basic Science or Stimuli for a Paradigm Shift in Biomanufacturing?
Apr 18, 2016
+3
byEric Roos, James A. Smithand 3 more
Decision-Support Tools for Monoclonal Antibody and Cell Therapy Bioprocessing: Current Landscape and Development Opportunities
MAb
Decision-Support Tools for Monoclonal Antibody and Cell Therapy Bioprocessing: Current Landscape and Development Opportunities
Decision-Support Tools for Monoclonal Antibody and Cell Therapy Bioprocessing: Current Landscape and Development Opportunities
Dec 16, 2015
+6
byRahul Rekhi, James A. Smithand 6 more
Quantitative Risk Assessment of Bioaccumulation Attributable to Extractables and Leachables in Cellular Immunotherapy Biomanufacturing
Cell Therapies
Quantitative Risk Assessment of Bioaccumulation Attributable to Extractables and Leachables in Cellular Immunotherapy Biomanufacturing
Quantitative Risk Assessment of Bioaccumulation Attributable to Extractables and Leachables in Cellular Immunotherapy Biomanufacturing
Nov 16, 2015
+2
byKevin Lannon, James A. Smithand 2 more
Extracellular Vesicles Commercial Potential As Byproducts of Cell Manufacturing for Research and Therapeutic Use
Cell Therapies
Extracellular Vesicles Commercial Potential As Byproducts of Cell Manufacturing for Research and Therapeutic Use
Extracellular Vesicles Commercial Potential As Byproducts of Cell Manufacturing for Research and Therapeutic Use
Apr 15, 2015
+9
byJames A. Smith, Kelvin S. Ngand 9 more
The Potential Application of Real‑Time Release Testing for the Biomanufacture of Autologous Cell‑Based Immunotherapies logo in a gray background | The Potential Application of Real‑Time Release Testing for the Biomanufacture of Autologous Cell‑Based Immunotherapies
Cell Therapies
The Potential Application of Real‑Time Release Testing for the Biomanufacture of Autologous Cell‑Based Immunotherapies
The Potential Application of Real‑Time Release Testing for the Biomanufacture of Autologous Cell‑Based Immunotherapies
Apr 15, 2015
+7
byDavid A. Brindley, Rahul Rekhiand 7 more

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Demonstrating a Modular Selectivity With a Weak AEX-HIC Resin for Achieving High mAb Purity and Recovery in a Downstream Process
Register Now: Demonstrating a Modular Selectivity With a Weak AEX-HIC Resin for Achieving High mAb Purity and Recovery in a Downstream Process
Insider News
See all
Mar 18 - Mar 21, 2025
SLASH TIME FROM BENCH TO BEDSIDE: Cutting-edge biomanufacturing for mAbs, vaccines, and advanced therapies. Bright ideas, bold science, and big innovations—delivering efficiency, precision, and quality through every phase of bioprocessing.
Learn More

Innovative Technology

Thermo Fisher Scientific peptones white paper
Sponsored Content
The Value of Peptones for Enhancing Biopharmaceutical Productivity
The Value of Peptones for Enhancing Biopharmaceutical Productivity

Jan 27, 2025

Nagase Trehalose SG
Sponsored Content
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG

Jan 9, 2025

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Subscribe